0000899243-21-006433.txt : 20210212
0000899243-21-006433.hdr.sgml : 20210212
20210212205120
ACCESSION NUMBER: 0000899243-21-006433
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210210
FILED AS OF DATE: 20210212
DATE AS OF CHANGE: 20210212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STEPHENSON BRIAN C
CENTRAL INDEX KEY: 0001780030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 21631441
MAIL ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-10
0
0001743881
BridgeBio Pharma, Inc.
BBIO
0001780030
STEPHENSON BRIAN C
C/O BRIDGEBIO PHARMA, INC.
421 KIPLING STREET
PALO ALTO
CA
94301
0
1
0
0
See Remarks
Stock Option (Right to Buy)
68.87
2021-02-10
4
A
0
73440
0.00
A
2031-02-09
Common Stock
73440
73440
D
Restricted Stock Units
2021-02-10
4
A
0
12449
0.00
A
Common Stock
12449
12449
D
The option will vest in 48 equal month installments after February 10, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
The units will vest in 16 equal quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.
Title: Secretary, Treasurer and Chief Financial Officer
/s/ Tara Condon, Attorney-in-Fact
2021-02-12